Phase II study of interval debulking surgery followed by intraperitoneal chemotherapy for advanced ovarian cancer: A Kansai Clinical Oncology Group study (KCOG9812)-Reference-Cited by-同舟云学术

Phase II study of interval debulking surgery followed by intraperitoneal chemotherapy for advanced ovarian cancer: A Kansai Clinical Oncology Group study (KCOG9812)

Published:2013-01 Issue:1 Volume:128 Page:22-27
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Tsubamoto Hiroshi,Itani Yoshio,Ito Kimihiko,Kanazawa Riichiro,Toyoda Shinji,Takeuchi Satoshi

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference38 articles.

1. Cancer statistics;Jemal;CA Cancer J Clin,2008

2. Consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004);du Bois;Ann Oncol,2005

3. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma;Griffiths;Natl Cancer Inst Monogr,1975

4. Identification of prognostic factors in advanced epithelial ovarian carcinoma;Chi;Gynecol Oncol.,2001

5. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis;Bristow;J Clin Oncol.,2002

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fertility‐sparing management of stage IIIC serous borderline ovarian tumor: A case report of a 20‐year follow‐up;Journal of Obstetrics and Gynaecology Research;2023-08-13

2. Neoadjuvant chemotherapy followed by fast-track cytoreductive surgery plus short-course hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: preliminary results of a promising all-in-one approach;Cancer Management and Research;2017-12

3. Fallopian Tube and Peritoneal Cancers;Textbook of Uncommon Cancer;2017-03-11

4. Positive peritoneal cytology at interval surgery is a poor prognostic factor in patients with stage T3c advanced ovarian carcinoma: A retrospective study;Journal of Obstetrics and Gynaecology Research;2014-11-25

5. No Residual Disease: The New Definition for Optimal Cytoreduction in Ovarian Cancer?;Clinical Ovarian and Other Gynecologic Cancer;2012-12